Table 3 Significant drug compounds with overlapped DEGs and p-value for hub DEGs. From the analysis of drug compounds, lucanthone and paclitaxel showed the high significance for the CC. Lucanthone and paclitaxel overlapped 10 and 9 hub DEGs respectively
From: Systematic approach to identify therapeutic targets and functional pathways for the cervical cancer
Drug compounds | Overlapped genes | p-value |
|---|---|---|
LUCANTHONE CTD 00006227 | 10 | 1.52E-20 |
Paclitaxel CTD 00007144 | 9 | 3.06E-14 |
Dasatinib CTD 00004330 | 9 | 3.60E-14 |
Troglitazone CTD 00002415 | 9 | 3.77E-13 |
Resveratrol MCF7 DOWN | 6 | 3.53E-12 |
Dasatinib CTD 00004330 | 9 | 3.60E-14 |